Pieter Westhuizen - Life Healthcare CFO, Executive Director

LTGHY Stock  USD 3.58  0.04  1.13%   

Director

Mr. Pieter P. van der Westhuizen CA, was appointed as Group Chief Financial Officer, Executive Director of the Company., effective February 1, 2018. He currently serves as Acting Group Chief Executive Officer, Group Chief Financial Officer, Executive Director of the Company. He currently serves as Chief Financial Officer, Executive Director of the Company. Pieter completed his training contract and qualified as a chartered accountant in 1996 at PricewaterhouseCoopers Inc. He joined President Medical Investments Limited in 1999, which became part of Afrox Healthcare Limited. Pieter performed various roles in the finance department of Afrox Healthcare and played a significant role in Afrox Healthcares delisting in 2005 and its subsequent relisting as Life Healthcare in 2010. He was appointed as Chief Financial Officer in 2013. since 2018.
Age 52
Tenure 6 years
Phone27 11 219 9000
Webhttps://www.lifehealthcare.co.za
Pieter completed his training contract and qualified in 1996 at PricewaterhouseCoopers Inc. He joined President Medical Investments Limited in 1999 which ultimately became part of Afrox Healthcare Limited. Pieter performed various roles in the finance department of Afrox Healthcare and played a significant role in Afrox Healthcare’s delisting in 2005 and its subsequent relisting as Life Healthcare in 2010. He was appointed as chief financial officer on 1 June 2013.

Life Healthcare Management Efficiency

The company has return on total asset (ROA) of 0.0404 % which means that it generated a profit of $0.0404 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0878 %, meaning that it generated $0.0878 on every $100 dollars invested by stockholders. Life Healthcare's management efficiency ratios could be used to measure how well Life Healthcare manages its routine affairs as well as how well it operates its assets and liabilities.
Life Healthcare Group has accumulated 10.33 B in total debt with debt to equity ratio (D/E) of 0.65, which is about average as compared to similar companies. Life Healthcare Group has a current ratio of 0.6, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Life Healthcare until it has trouble settling it off, either with new capital or with free cash flow. So, Life Healthcare's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Life Healthcare Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Life to invest in growth at high rates of return. When we think about Life Healthcare's use of debt, we should always consider it together with cash and equity.
Life Healthcare Group Holdings Limited, together with its subsidiaries, operates private hospitals in South Africa, Canada, the United Kingdom, rest of Europe, and Internationally. Life Healthcare Group Holdings Limited was founded in 1983 and is headquartered in Johannesburg, South Africa. Life Healthcare is traded on OTC Exchange in the United States. Life Healthcare Group [LTGHY] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Life Healthcare Group Leadership Team

Elected by the shareholders, the Life Healthcare's board of directors comprises two types of representatives: Life Healthcare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Life. The board's role is to monitor Life Healthcare's management team and ensure that shareholders' interests are well served. Life Healthcare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Life Healthcare's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yvonne Motsisi, Group Marketing and Communications Executive
Rajit Mehta, Managing Director - Max Healthcare
Mark Ferreira, Group Officer
Pieter Westhuizen, CFO, Executive Director
Adam Pyle, Group Strategy and Investor Relations Executive
BCom Harvard, Group Director
Avanthi Parboosing, Group Company Secretary
Joshila Ranchhod, Group Sec
Megan Naidoo, Chief Africa
Mark Chapman, International CEO

Life Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Life Healthcare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Life Pink Sheet Analysis

When running Life Healthcare's price analysis, check to measure Life Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Life Healthcare is operating at the current time. Most of Life Healthcare's value examination focuses on studying past and present price action to predict the probability of Life Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Life Healthcare's price. Additionally, you may evaluate how the addition of Life Healthcare to your portfolios can decrease your overall portfolio volatility.